152 related articles for article (PubMed ID: 32922552)
1. TMT-labeling Proteomics of Papillary Thyroid Carcinoma Reveal Invasive Biomarkers.
Dai J; Yu X; Han Y; Chai L; Liao Y; Zhong P; Xie R; Sun X; Huang Q; Wang J; Yin Z; Zhang Y; Lv Z; Jia C
J Cancer; 2020; 11(20):6122-6132. PubMed ID: 32922552
[No Abstract] [Full Text] [Related]
2. TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas.
Wang Y; Cheng T; Lu M; Mu Y; Li B; Li X; Zhan X
EPMA J; 2019 Dec; 10(4):395-414. PubMed ID: 31832114
[TBL] [Abstract][Full Text] [Related]
3. Proteomics profiling for the global and acetylated proteins of papillary thyroid cancers.
Wei W; Wu Y; Chen DD; Song Y; Xu G; Shi Q; Dong XP
Proteome Sci; 2023 Apr; 21(1):6. PubMed ID: 37101287
[TBL] [Abstract][Full Text] [Related]
4. In-Depth Proteomics Analysis to Identify Biomarkers of Papillary Thyroid Cancer Patients Older Than 45 Years with Different Degrees of Lymph Node Metastases.
Zhan S; Wang T; Wang M; Li J; Ge W
Proteomics Clin Appl; 2019 Sep; 13(5):e1900030. PubMed ID: 31148369
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential diagnostic and prognostic biomarkers for papillary thyroid microcarcinoma (PTMC) based on TMT-labeled LC-MS/MS and machine learning.
Li J; Mi L; Ran B; Sui C; Zhou L; Li F; Dionigi G; Sun H; Liang N
J Endocrinol Invest; 2023 Jun; 46(6):1131-1143. PubMed ID: 36418670
[TBL] [Abstract][Full Text] [Related]
6. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.
Wen DY; Pan DH; Lin P; Mo QY; Wei YP; Luo YH; Chen G; He Y; Chen JQ; Yang H
Mol Med Rep; 2018 Sep; 18(3):2631-2642. PubMed ID: 30015845
[TBL] [Abstract][Full Text] [Related]
8. Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.
Ab Mutalib NS; Othman SN; Mohamad Yusof A; Abdullah Suhaimi SN; Muhammad R; Jamal R
PeerJ; 2016; 4():e2119. PubMed ID: 27350898
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of TPO and AOX1 in pediatric papillary thyroid carcinoma.
Yu Y; Wang S; Zhang X; Xu S; Li Y; Liu Q; Yang Y; Sun N; Liu Y; Zhang J; Guo Y; Ni X
Transl Pediatr; 2021 Apr; 10(4):723-732. PubMed ID: 34012822
[TBL] [Abstract][Full Text] [Related]
10. Identification of Genes Associated with Papillary Thyroid Carcinoma (PTC) for Diagnosis by Integrated Analysis.
Li WB; Zhou J; Xu L; Su XL; Liu Q; Pang H
Horm Metab Res; 2016 Apr; 48(4):226-31. PubMed ID: 26756467
[TBL] [Abstract][Full Text] [Related]
11. The contribution of chronic intermittent hypoxia to OSAHS: From the perspective of serum extracellular microvesicle proteins.
Zhang H; Yang F; Guo Y; Wang L; Fang F; Wu H; Nie S; Wang Y; Fung ML; Huang Y; Deng H; Qin Y; Ma X; Wei Y
Metabolism; 2018 Aug; 85():97-108. PubMed ID: 29522771
[TBL] [Abstract][Full Text] [Related]
12. Proteomics study of serum exosomes from papillary thyroid cancer patients.
Luo D; Zhan S; Xia W; Huang L; Ge W; Wang T
Endocr Relat Cancer; 2018 Oct; 25(10):879-891. PubMed ID: 29895528
[TBL] [Abstract][Full Text] [Related]
13. PDLIM5 identified by label-free quantitative proteomics as a potential novel biomarker of papillary thyroid carcinoma.
Wei X; Zhang Y; Yu S; Li S; Jiang W; Zhu Y; Xu Y; Yang C; Tian G; Mi J; Bergquist J; Zhao M; Song F
Biochem Biophys Res Commun; 2018 May; 499(2):338-344. PubMed ID: 29574154
[TBL] [Abstract][Full Text] [Related]
14. Screening differentially expressed proteins of coronary heart disease with congenital cold syndrome based on tandem mass tag (TMT) technology.
Xie T; Guo J; Jiang Y; Li L; Jiang L; Wei Y
Bioengineered; 2021 Dec; 12(1):1338-1350. PubMed ID: 33904367
[TBL] [Abstract][Full Text] [Related]
15. iTRAQ-coupled 2D LC/MS-MS analysis of CXCR7-transfected papillary thyroid carcinoma cells: A new insight into CXCR7 regulation of papillary thyroid carcinoma progression and identification of potential biomarkers.
Zhang H; Yang L; Liu Z; Liu C; Teng X; Zhang L; Yin B; Liu Z
Oncol Lett; 2017 Sep; 14(3):3734-3740. PubMed ID: 28927140
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Wu M; Yuan H; Li X; Liao Q; Liu Z
Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
[No Abstract] [Full Text] [Related]
17. New insights into pathogenesis of congenital pseudarthrosis of tibia in children using periosteum proteomics analysis.
Liu Y; Qin ZQ; Zheng Y; Wu J; Yang G; Tan Q; Zhu G; Liu K; Mei H
Rapid Commun Mass Spectrom; 2022 Nov; 36(21):e9374. PubMed ID: 35933588
[TBL] [Abstract][Full Text] [Related]
18. The Landscape of Circular RNA Expression Profiles in Papillary Thyroid Carcinoma Based on RNA Sequencing.
Lan X; Xu J; Chen C; Zheng C; Wang J; Cao J; Zhu X; Ge M
Cell Physiol Biochem; 2018; 47(3):1122-1132. PubMed ID: 29847813
[TBL] [Abstract][Full Text] [Related]
19. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Zhao H; Li H
Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
[TBL] [Abstract][Full Text] [Related]
20. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
